Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (161-170 of 308) with videos related to

Pageof 31
Sort By:
Journal of Neuro-Oncology|September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapyHideho Okada, Frank S Lieberman, Howard D Edington, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group StudyStewart Goldman, Eric Bouffet, Paul G Fisher, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Plastic and Reconstructive Surgery|August 26, 2017
A Treatment Algorithm for Patients Presenting with Sagittal Craniosynostosis after the Age of 1 YearEdward J Ruane, Catharine B Garland, Liliana Camison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001)Susan M Blaney, James Boyett, Henry Friedman, et al.
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
Pageof 31

Showing results (161-170 of 308) with videos related to

Sort By:
Pageof 31
Journal of Neuro-Oncology|September 4, 2003
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapyHideho Okada, Frank S Lieberman, Howard D Edington, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Journal of Neuro-Oncology|September 15, 2016
Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot studyIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Pediatric Blood & Cancer|September 17, 2013
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology GroupVandana Batra, Stephen A Sands, Emi Holmes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group StudyStewart Goldman, Eric Bouffet, Paul G Fisher, et al.
Neuro-Oncology|March 18, 2016
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasIan F Pollack, Regina I Jakacki, Lisa H Butterfield, et al.
Plastic and Reconstructive Surgery|August 26, 2017
A Treatment Algorithm for Patients Presenting with Sagittal Craniosynostosis after the Age of 1 YearEdward J Ruane, Catharine B Garland, Liliana Camison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001)Susan M Blaney, James Boyett, Henry Friedman, et al.
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
Pageof 31